Pharmazell (India) Private Limited

Pharmazell (India) Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24294TN1993PTC025852 Incorporated 22 September 1993 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Revenue · FY 2025
₹524.65 Cr
▲ 3% YoY
Net profit · FY 2025
₹54.82 Cr
Net margin 10.4%
EBITDA · FY 2025
₹101.44 Cr
EBITDA margin 19.3%
Authorised capital
₹65 Cr
Registered with MCA
Paid-up capital
₹10.92 Cr
Issued & subscribed
Satisfied charges
₹15.58 Cr
No open charges
Company age
33 yrs
Est. 1993
Employees · EPFO
531
Provident fund records

About Pharmazell (India) Private Limited

Data last updated:

Pharmazell (India) Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 September 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24294TN1993PTC025852. Its GSTIN is 33AAACD3338F1Z5 (Tamil Nadu). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹65 Cr and a paid-up capital of ₹10.92 Cr. It was formerly known as Diamalt Pharmorganica Private Limited and Bf Goodrich Diamalt Private Limited. It is led by directors including Anant Dattatray Barbadikar (Managing Director) and Nagarajan Karthik (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.B5 & B6 Madras Exportprocessing Zone Tambaram Madras – 600045, Chennai, Tamil Nadu, India – 600045.

As per the financials filed for FY 2025, the company reported a revenue of ₹524.65 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹54.82 Cr (net margin 10.4%) and EBITDA of ₹101.44 Cr (EBITDA margin 19.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.

The company has about 531 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Pharmazell Group. As per MCA filings, the company has satisfied charges of ₹15.58 Cr on record. Court records list 21 cases involving the company, including 21 filed by the company. The company has 1 deal on record (1 funding round), with disclosed funding of ₹6.42 Cr; the latest was in September 2020. Its 3 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (manufacture of chemicals and chemical products) are compared by revenue, 1 larger and 2 smaller; the largest is Raichem Medicare Private Limited with revenue of ₹515.04 Cr. The company has 15 MSME Form 1 returns on record between 2016 and 2023, listing 166 overdue payments to 55 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmazell.com.

Company details

CIN U24294TN1993PTC025852
Registration Number 025852
Incorporation Date 22 September 1993
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Name history

Pharmazell (India) has undergone 2 name changes throughout its history. The company was previously known as Diamalt Pharmorganica Private Limited, and Bf Goodrich Diamalt Private Limited. The current legal name is Pharmazell (India) Private Limited.

Company NameStatus
Pharmazell (India) Private LimitedCurrent
Diamalt Pharmorganica Private LimitedPrevious
Bf Goodrich Diamalt Private LimitedPrevious

Contact details

Pharmazell (India) Private Limited's registered office is in Chennai, Tamil Nadu. Its website is pharmazell.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No.B5 & B6 Madras Exportprocessing Zone Tambaram Madras – 600045, Chennai, Tamil Nadu, India – 600045
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Pharmazell (India) Private Limited, buy the company report.

Comprehensive company report
Pharmazell (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Pharmazell (India) operates one associated brand: Pharmazell Group. Each brand links to its own profile.

BrandDescriptionWebsite
Active pharmaceutical ingredients are manufactured by Pharmazell Group.pharmazell-group.com

Business activity

The main business activity of Pharmazell (India) is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Pharmazell (India) Private Limited, buy the company report.

Financials of Pharmazell (India) Private Limited

FY 2025 filings available

Pharmazell (India) Private Limited reported revenue of ₹524.65 Cr (up 3% YoY) for FY 2025.

Revenue · FY 2025
₹524.65 Cr ▲ 3%
Net profit · FY 2025
₹54.82 Cr margin 10.4%
EBITDA · FY 2025
₹101.44 Cr margin 19.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 13%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 36%
5 years · compounded
▲ 29%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 3% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹524.65 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹101.44 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹54.82 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin19.3%
Net Profit Margin10.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pharmazell (India) Private Limited, buy the company report.

Board of directors of Pharmazell (India) Private Limited

Pharmazell (India) has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nagarajan KarthikWhole-Time Director01 Apr 20242 Years 7 MonthsCurrent
Appa Rao SuryadevaraWhole-Time Director01 Apr 20242 Years 7 MonthsCurrent
Sukumar ManiWhole-Time Director01 Apr 20242 Years 7 MonthsCurrent
Anant Dattatray BarbadikarManaging Director19 Feb 201016 Years 8 MonthsCurrent

Peer comparison

Pharmazell (India) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pharmazell (India) Private Limitedthis company₹524.65 Cr (FY 2025)₹54.82 Cr10.4%3.0%531Chennai, Tamil Nadu, India
Raichem Medicare Private Limited₹515.04 Cr (FY 2025)-12.0%Chicksugur Village, Karnataka, India
Sudarshan Pharma Industries Limited₹507.57 Cr (FY 2025)9.0%Mumbai, Maharashtra, India
Aarey Drugs and Pharmaceuticals Limited₹483.76 Cr (FY 2025)20.0%Thane, Maharashtra, India

To see the full peer comparison of Pharmazell (India) Private Limited, buy the company report.

Auditor

Pharmazell (India) Private Limited is audited by M S K A & Associates for the financial year 2025.

Auditor firmFinancial yearFirm registration number
M S K A & AssociatesFY 2025105047W

Shareholding

The shareholding of Pharmazell (India) Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pharmazell (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹15.58 Cr
Breakdown by lending institutions
Others₹15.58 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 Mar 2016100026057Others₹15.58 CrSatisfied

To see the full charge records of Pharmazell (India) Private Limited, buy the company report.

Total charge records: 1 View all charges

Deals & funding

Pharmazell (India) Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹6.42 Cr; the latest was in September 2020.

Total deals
1
Funding round
1
Disclosed funding
₹6.42 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Sep 2020Funding round₹6.42 CrInvestors: Pharmazell Gmbh, Zellbios Gmbh

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Pharmazell (India) Private Limited has 15 MSME Form 1 returns on record between 2016 and 2023, listing 166 overdue payments to 55 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 55)

SupplierAmount dueDue sinceReported on
Mak Clean Air Systems Private Limited
Allyone Environmental Technologies India Private Limited
Skylark Uniforms
an individual supplier
Chempharm Industries India Private Limited

To see the full MSME payment records of Pharmazell (India) Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Pharmazell (India) has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Pharmachol Chemicals Private LimitedU36100HR2016PTC058478

To see the full group structure of Pharmazell (India) Private Limited, buy the company report.

Employees & EPFO

Pharmazell (India) Private Limited has a workforce of 531 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
531
Active EPFO establishments
2
Employee growth
3.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27531
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Pharmazell (India) Private Limited, buy the company report.

GST

Pharmazell (India) has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
33AAACD3338F1Z5Tamil NaduActive01 Jul 2017
37AAACD3338F1ZXAndhra PradeshActive17 Mar 2020

To see the full GST registrations and return filing status of Pharmazell (India) Private Limited, buy the company report.

Recent activity

Pharmazell (India) Private Limited has 12 board changes on record since 2010: 4 appointments and 8 cessations. The latest: Appa Rao Suryadevara ceased to be Director on 16 Apr 2024.

Filing
Pharmazell (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
AGM
Pharmazell (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Appa Rao Suryadevara ceased to be Director.
Ceased
Sukumar Mani ceased to be Director.
Appointed
Appa Rao Suryadevara was appointed as Whole-Time Director.
Appointed
Nagarajan Karthik was appointed as Whole-Time Director.
Ceased
Nagarajan Karthik ceased to be Director.
Appointed
Sukumar Mani was appointed as Whole-Time Director.
Ceased
Oliver Valentin Bolzern ceased to be Director.
Charges
A charge registered on 23 Mar 2016 via Charge ID 100026057 with Others was fully satisfied on 22 Dec 2020.
Ceased
Manoharan ceased to be Additional Director.
Charges
A charge with Others of Rs. 15.58 Cr registered on 23 Mar 2016 with Charge ID 100026057 was modified on 02 Feb 2018.

6 earlier events are in the company report.

News

Frequently asked questions

Pharmazell (India) is an active private limited company based in Chennai, Tamil Nadu, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 22 September 1993 (33+ years old) and is registered under CIN U24294TN1993PTC025852.

Pharmazell (India) has 4 current directors:

The latest financial statements of Pharmazell (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Pharmazell (India) is 33AAACD3338F1Z5, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAACD3338F1ZX (Andhra Pradesh).

The CIN (Corporate Identification Number) of Pharmazell (India) is U24294TN1993PTC025852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pharmazell (India) has 21 court cases on record: 21 filed by the company.

Pharmazell (India) was incorporated on 22 September 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chennai.

Pharmazell (India) has 1 deal on record (1 funding round), with disclosed funding of ₹6.42 Cr; the latest was in September 2020.

The peers of Pharmazell (India) by revenue are Raichem Medicare Private Limited, Sudarshan Pharma Industries Limited, Aarey Drugs and Pharmaceuticals Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (manufacture of chemicals and chemical products).

Appa Rao Suryadevara ceased to be Director on 16 Apr 2024. Sukumar Mani ceased to be Director on 16 Apr 2024. Appa Rao Suryadevara was appointed as Whole-Time Director on 01 Apr 2024. Pharmazell (India) has 12 board changes on record in total.

Pharmazell (India) has 15 MSME Form 1 returns on record between 2016 and 2023, listing 166 overdue payments to 55 micro and small suppliers. The latest return was filed on 05 Dec 2023.

Pharmazell (India) can be reached through the website pharmazell.com. Its registered office is in Chennai, Tamil Nadu, India.